Format

Send to

Choose Destination
Radiol Clin North Am. 2012 Nov;50(6):1075-83. doi: 10.1016/j.rcl.2012.08.005. Epub 2012 Oct 11.

Imaging of recurrent prostate cancer.

Author information

1
Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. j.futterer@rad.umcn.nl

Abstract

Approximately 30% of patients who underwent radical prostatectomy or radiation therapy will develop biochemical recurrent disease. Biochemical recurrent disease is defined as an increase in the serum value of prostate-specific antigen (PSA) after reaching the nadir. Prostate recurrence can present as PSA-only relapse, local recurrent disease, distant metastases, or a combination of local and distant recurrence. In this review, the role of magnetic resonance imaging in the work-up of recurrent prostate cancer is discussed.

PMID:
23122039
DOI:
10.1016/j.rcl.2012.08.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center